Alentemol (hydrobromide)


CAS No. : 112892-81-6

(Synonyms: U-68553B)

112892-81-6
Price and Availability of CAS No. : 112892-81-6
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-115418
M.Wt: 364.32
Formula: C19H26BrNO
Purity: >98 %
Solubility:
Introduction of 112892-81-6 :

Alentemol hydrobromide (U-66444B) is a blood-brain barrier-permeable dopamine receptor D1, D2, D3, and D4 agonist. Alentemol hydrobromide inhibits dopamine release, reduces dopamine synthesis, regulates dopamine metabolism, suppresses the impulse activity of dopaminergic neurons, and decreases the impulse frequency of dopaminergic neurons in the substantia nigra pars compacta and ventral tegmental area. Alentemol hydrobromide is applicable to research related to schizophrenia[1][2][3]. In Vivo:Alentemol hydrobromide (U-66444B) (0.0001-10.0 mg/kg; i.p., s.c., p.o.) acts as a potent presynaptic dopamine receptor agonist in healthy male CF-1 mice, inducing hypothermia, inhibiting locomotor activity, antagonizing d-amphetamine-stimulated activity, reducing dopamine release, and demonstrating oral and subcutaneous bioavailability in the brain[1].
Alentemol hydrobromide (0.001-0.1 mg/kg; s.c.) inhibits dopamine synthesis in healthy male Sprague-Dawley rats, with enhanced efficacy when presynaptic terminals are isolated from postsynaptic feedback via gamma-butyrolactone[1].
Alentemol hydrobromide (3.0 μg/kg; i.v.; single dose; 6 mg/kg; daily; 14 days) acts as a potent dopaminergic autoreceptor agonist with an ED50 of 3.0 μg/kg i.v. for inhibiting SNPC neurons, three times more potent than Apomorphine (HY-12723), and shows weak tolerance development following 14 days of daily 6 mg/kg administration[2].

Your information is safe with us.